Skip to content

Development of endoscopic submucosal dissection using new endoscopic device (Hood Clipper)

Development of endoscopic submucosal dissection using new endoscopic device (Hood Clipper) - New endoscopic device (Hood Clipper) for endoscopic submucosal dissection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000003547
Enrollment
50
Registered
2010-05-01
Start date
2006-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric,esopahgeal and rectal cancer

Interventions

Endoscopic submucosal dissection

Sponsors

Kyoto University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Depth of invasion was limited to the mucosa or thin layer of submucosa (evaluated by endoscopy and /or endoscopic ultrasonography). (2) N0M0 eavluated by CT scan (if submucosal invasion was suspected). (3) Performance status(ECOG) is 0 or 1. (4) fulfill all the criteria indicated below (within 30 days before treatment, ULN: upper limit of the institution). i) white blood cell count no fewer than 3000/mm3 no more than 10000/mm3 ii) hemoglobin more than 9.0 g/dl(No blood transfusion was done within 14 days before treatment). iii) platelet count more than 100,000/mm3 iv) GOT less or equal ULN X2.5 v) GPT less or equal ULN X2.5 vi) T-Bil less or equal 3.0mg/ml vi) serum creatinine less or equal 2.0mg/ml (5) Written informed consent is essential.

Exclusion criteria

Exclusion criteria: (1) Cases with the component of poorly differetiated carcinoma in the biopsy specimen. (2) Cases with active multiple cancers. (3) Cases with severe complication.(i.e., decompensated liver cirrhosis, severe ischemic heart disease and renal failure, poorly-controlled diabetes mellitus, chronic respiratory failure requiring for continuous oxygen administration, Discontinuation of anticoagulant therapy can not be allowed). (4) Woman in pregnancy (or woman of child bearing potential) and breast-feeding woman. (5) Cases with uncontrolled psychiatric disease.

Design outcomes

Primary

MeasureTime frame
Primary endpoint of this study is to evaluate the operation time of submucosal dissection using new device.

Secondary

MeasureTime frame
1) enbloc resection rate 2) safety

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026